- Home
- SPCB vs GDTC Comparison
SPCB vs GDTC Comparison
Compare SPCB & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- GDTC
- Stock Information
- Founded
- SPCB 1988
- GDTC 2018
- Country
- SPCB Israel
- GDTC Singapore
- Employees
- SPCB N/A
- GDTC N/A
- Industry
- SPCB Semiconductors
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- GDTC Health Care
- Exchange
- SPCB Nasdaq
- GDTC Nasdaq
- Market Cap
- SPCB 53.3M
- GDTC 28.0M
- IPO Year
- SPCB N/A
- GDTC 2023
- Fundamental
- Price
- SPCB $9.66
- GDTC $2.05
- Analyst Decision
- SPCB Strong Buy
- GDTC Buy
- Analyst Count
- SPCB 1
- GDTC 1
- Target Price
- SPCB $18.00
- GDTC $5.00
- AVG Volume (30 Days)
- SPCB 131.4K
- GDTC 6.7K
- Earning Date
- SPCB 08-14-2025
- GDTC 01-01-0001
- Dividend Yield
- SPCB N/A
- GDTC N/A
- EPS Growth
- SPCB N/A
- GDTC N/A
- EPS
- SPCB 1.89
- GDTC N/A
- Revenue
- SPCB $27,831,000.00
- GDTC $368,838.00
- Revenue This Year
- SPCB $2.73
- GDTC $5.37
- Revenue Next Year
- SPCB $22.87
- GDTC N/A
- P/E Ratio
- SPCB $5.20
- GDTC N/A
- Revenue Growth
- SPCB 2.90
- GDTC N/A
- 52 Week Low
- SPCB $2.55
- GDTC $1.20
- 52 Week High
- SPCB $18.95
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- SPCB 45.50
- GDTC 45.73
- Support Level
- SPCB $9.23
- GDTC $2.12
- Resistance Level
- SPCB $11.00
- GDTC $2.22
- Average True Range (ATR)
- SPCB 0.61
- GDTC 0.09
- MACD
- SPCB -0.14
- GDTC -0.00
- Stochastic Oscillator
- SPCB 22.99
- GDTC 28.57
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.